Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Lung Transplantation
96%
Non Small Cell Lung Cancer
95%
Lung
61%
Overall Survival
46%
Lung Cancer
45%
Clinical Stage
38%
Esophageal Cancer
28%
Esophagectomy
26%
Lobectomy
25%
Odds Ratio
25%
Malignant Neoplasm
25%
Pneumonectomy
24%
Surgeon
23%
Hazard Ratio
23%
Thorax Surgery
20%
Lymph Node
17%
Health Care Cost
17%
Stereotactic Body Radiation Therapy
16%
Primary Graft Dysfunction
15%
Diseases
14%
Computer Assisted Tomography
14%
Veterans Health
14%
Neoplasm
13%
Comorbidity
13%
Radiation Therapy
12%
Video-Assisted Thoracoscopic Surgery
11%
Cost-Effectiveness Analysis
11%
Tumor
10%
Adjuvant Chemotherapy
10%
Chemoradiotherapy
10%
Lung Cancer Screening
9%
Logistic Regression Analysis
9%
Charlson Comorbidity Index
9%
Prostate Cancer
9%
Organ Donor
9%
Allograft
9%
Adjuvant Therapy
9%
Organ Transplantation
8%
Retrospective Cohort Study
8%
Prevalence
8%
Clinical Trial
7%
Prescription Medication
7%
Proportional Hazards Model
7%
Heart Transplantation
7%
Acute Graft Rejection
7%
Recurrent Disease
7%
Cancer Surgery
6%
Long Term Survival
6%
COVID-19
6%
Donor Management
6%
Keyphrases
Lung Transplantation
100%
Non-small Cell Lung Cancer (NSCLC)
55%
Stage I Lung Cancer
40%
Confidence Interval
35%
Overall Survival
33%
Lung Cancer
31%
Esophageal Cancer
28%
Lung
28%
Early-stage Lung Cancer
25%
Resection
21%
Esophagectomy
20%
Clinical Stage I
19%
Primary Graft Dysfunction
19%
Transplantation
19%
National Cancer Database
17%
Improved Survival
17%
Hazard Ratio
16%
Donor Lung
15%
Odds Ratio
15%
Surgical Resection
15%
Surgical Treatment
14%
Pathologic
14%
Lobectomy
13%
Thoracic Surgery
13%
Stereotactic Body Radiation Therapy
12%
Adjuvant Chemotherapy
11%
Veterans Health Administration
11%
Induction Therapy
10%
Computed Tomography
10%
Healthcare Facilities
10%
Donor Care
10%
Charlson Comorbidity Index
10%
Lung Cancer Screening
10%
Lung Donor
9%
Surgeons
9%
Video-assisted Thoracoscopic Surgery
8%
Surgical Outcomes
8%
Clinical Outcomes
8%
30-day Mortality
8%
Society of Thoracic Surgeons
8%
Size Matching
8%
Lung Resection
8%
Allocation Policy
8%
Adjuvant Therapy
8%
Prescription Drugs
7%
Pathological Stage
7%
Pulmonary Resection
7%
5-year Survival
7%
United States
7%
Increasing Age
7%